Elevated Systolic BP in Type 2 Diabetes Increases Cardiovascular Risk.
Stamler J et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16(2):434–44.
Reproduced with permission from The Lancet; Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial. 2010;376(9756):1903–9.